Substance | <15 | 15-19 | 20-24 | 25-29 | 30-34 | 35-39 | 40-44 | 45+ | Age known | Age not known |
---|---|---|---|---|---|---|---|---|---|---|
Opioids | 3.1 | 16.8 | 31.8 | 45.9 | 54.6 | 59.3 | 60.5 | 46.9 | 14819 | 23 |
Cocaine | 7.8 | 3.3 | 5.1 | 6.7 | 8.2 | 8.7 | 9.0 | 7.6 | 2258 | 0 |
Stimulants | 12.5 | 21.8 | 18.1 | 15.5 | 12.5 | 8.9 | 6.6 | 5.5 | 4264 | 3 |
Hypnotics and sedatives | 1.6 | 1.4 | 2.8 | 3.2 | 3.7 | 4.3 | 6.4 | 22.0 | 1716 | 4 |
Hallucinogens | 0.0 | 0.7 | 0.5 | 0.4 | 0.2 | 0.3 | 0.2 | 0.1 | 107 | 1 |
Volatile substances | 17.2 | 4.5 | 0.6 | 0.7 | 0.4 | 0.4 | 0.2 | 0.1 | 249 | 0 |
Cannabis | 45.3 | 39.9 | 28.1 | 16.5 | 11.2 | 10.4 | 8.7 | 7.2 | 5460 | 10 |
Other substances | 12.5 | 11.6 | 13.1 | 11.1 | 9.2 | 7.8 | 8.5 | 10.6 | 3365 | 18 |
Total | 64 | 2190 | 6097 | 7442 | 6402 | 4215 | 2709 | 3119 | 32238 | 59 |
The number of treatment clients in each country is listed in Table TDI-7.
See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.
Reitox national reports 2012 — Table TDI outpatient and inpatient treatment centres.